ARTIFICIAL CELL TECHNOLOGIES, INC.
Synthetic microparticle vaccine for malaria using layer-by-layer fabrication with T1BT* epitopes
- Sector
- Biotech
- Total capital
- $1.3M
- Federal grants
- $1.3M
- 1 award · 2015
- Rank in peer group#227 of 326
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 7
- 16 pending · first 2014
- Rank in peer group#25 of 326
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Synthetic microparticle malaria vaccine$1.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 326 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#25 · top 8%
- Linked publications#19 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 7 granted of 23- PendingRespiratory Syncytial Virus Antigenic Compositions And MethodsUSPTOApplication 18188730
- PendingAnti-malaria Compositions And MethodsUSPTOApplication 17553098
- PendingAnti-malaria Compositions And MethodsUSPTOApplication 16589540
Show all 23 patent records
- Respiratory Syncytial Virus Antigenic Compositions And MethodsDec 28, 2023 · Application 18188730Pending
- Anti-malaria Compositions And MethodsMar 31, 2022 · Application 17553098Pending
- Anti-malaria Compositions And MethodsApr 9, 2020 · Application 16589540Pending
- Anti-malaria Compositions And MethodsMar 17, 2020 · US 10,588,954Granted
- Automated Layer By Layer Construction Of Multilayer Coated Cores By TffMay 22, 2018 · US 9,975,066Granted
- Anti-malaria Compositions And MethodsMay 15, 2018 · US 9,968,665Granted
- Antigenic Compositions And MethodsMar 27, 2018 · US 9,925,252Granted
- Anti-malaria Compositions And MethodsSep 6, 2016 · US 9,433,671Granted
- Antigenic Compositions And MethodsApr 5, 2016 · US 9,302,001Granted
- Antigenic Compositions And MethodsNov 11, 2014 · US 8,883,717Granted
- Anti-malaria Compositions And MethodsApplication PCTUS2013033070Pending
- Respiratory Syncytial Virus Antigenic Compositions And MethodsApplication PCTUS2011043136Pending
- Administration Regimens For Microneedle Patch Devices For Delivery Of Immunogenic CompositionsApplication PCTUS2023074634Pending
- Polypeptide Films And MethodsApplication PCTUS2008000805Pending
- Respiratory Syncytial Virus Antigenic Compositions And MethodsApplication PCTUS2023064904Pending
- Respiratory Syncytial Virus Antigenic Compositions And MethodsApplication 63324824Pending
- Anti-malaria Compositions And MethodsApplication PCTUS2019053930Pending
- Anti-malaria Compositions And MethodsApplication 62741198Pending
- Anti-malaria Compositions And MethodsApplication PCTUS2016051469Pending
- Anti-malaria Compositions And MethodsApplication 62219260Pending
- Automated Layer By Layer Construction Of Multilayer Coated Cores By TffApplication PCTUS2015032108Pending
- Automated Layer By Layer Construction Of Multilayer Coated Cores By TffApplication 62003242Pending
- Antigenic Compositions And MethodsApplication PCTUS2013033071Pending
Recent research by its founders
- Determining T-cell receptor binding orientation and Peptide-HLA interactions using cross-linking mass spectrometry20251 cites
- Layer-by-Layer Microparticle Vaccines Containing a S177Q Point Mutation in the Central Conserved Domain of the RSV G Protein Improves Immunogenicity20250 cites
- Tandem mass spectrometry fragmentation patterns of sulfo-SDA cross-linked peptides20250 cites
Related companies, and why
- OnKure, Inc.Similar federal contract value in Biotech · null in contracts
- LUMINARY THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- Numab TherapeuticsSimilar federal contract value in Biotech · null in contracts
- RADOPTICS, LLCSimilar federal contract value in Biotech · null in contracts
- QUIVIVE PHARMA, INCSimilar federal contract value in Biotech · null in contracts
- Initos Pharmaceuticals LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .